Clinical Trial

BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDs

Recruiting
View on ClinicalTrials.gov →
Summary
The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock\_BC (Ilivia Neo, Intica Neo) implant and programmer software features. The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky). The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-11
notable Trial sites expanded: 0 -> 7 locations 2026-07-11
Trial Details
NCT Number NCT07360158
Lead Sponsor Biotronik SE & Co. KG
Conditions Tachyarrhythmia, Heart Failure
Enrollment 151 participants
Start Date 2026-06-22
Primary Completion 2027-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-10